Literature DB >> 16495141

Apolipoprotein A-I lysine modification: effects on helical content, lipid binding and cholesterol acceptor activity.

Gregory Brubaker1, Dao-Quan Peng, Benjamin Somerlot, Davood J Abdollahian, Jonathan D Smith.   

Abstract

We examined the role of the positively charged lysine residues in apoAI by chemical modification. Lysine modification by reductive methylation did not alter apoAI's net charge, secondary or tertiary structure as observed by circular dichroism and trytophan fluorescence, respectively, or have much impact on lipid binding or ABCA1-dependent cholesterol acceptor activity. Acetylation of lysine residues lowered the isoelectric point of apoAI, altered its secondary and tertiary structure, and led to a 40% decrease in cholesterol acceptor activity, while maintaining 93% of its lipid binding activity. Exhaustive lysine acetoacetylation lowered apoAI's isoelectric point, profoundly disrupted its secondary and tertiary structure, and led to 90% and 82% reductions in cholesterol acceptor and lipid binding activities, respectively. The dose-dependent acetoacetylation of an increasing proportion of apoAI lysine residues demonstrated that cholesterol acceptor activity was more sensitive to this modification than lipid binding activity, suggesting that apoAI lysine positive charges play an important role in ABCA1 mediated lipid efflux beyond the role needed to maintain alpha-helical content and lipid binding activity.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16495141     DOI: 10.1016/j.bbalip.2006.01.007

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  18 in total

1.  Myeloperoxidase, inflammation, and dysfunctional high-density lipoprotein.

Authors:  Jonathan D Smith
Journal:  J Clin Lipidol       Date:  2010 Sep-Oct       Impact factor: 4.766

2.  Methionine oxidized apolipoprotein A-I at the crossroads of HDL biogenesis and amyloid formation.

Authors:  Andrzej Witkowski; Gary K L Chan; Jennifer C Boatz; Nancy J Li; Ayuka P Inoue; Jaclyn C Wong; Patrick C A van der Wel; Giorgio Cavigiolio
Journal:  FASEB J       Date:  2018-01-17       Impact factor: 5.191

3.  Conformational and aggregation properties of the 1-93 fragment of apolipoprotein A-I.

Authors:  Jitka Petrlova; Arnab Bhattacherjee; Wouter Boomsma; Stefan Wallin; Jens O Lagerstedt; Anders Irbäck
Journal:  Protein Sci       Date:  2014-08-23       Impact factor: 6.725

4.  The "beta-clasp" model of apolipoprotein A-I--a lipid-free solution structure determined by electron paramagnetic resonance spectroscopy.

Authors:  Jens O Lagerstedt; Madhu S Budamagunta; Grace S Liu; Nicole C DeValle; John C Voss; Michael N Oda
Journal:  Biochim Biophys Acta       Date:  2012-01-08

5.  Advanced glycation of apolipoprotein A-I impairs its anti-atherogenic properties.

Authors:  A Hoang; A J Murphy; M T Coughlan; M C Thomas; J M Forbes; R O'Brien; M E Cooper; J P F Chin-Dusting; D Sviridov
Journal:  Diabetologia       Date:  2007-06-20       Impact factor: 10.122

6.  Apolipoprotein A-I binding to anionic vesicles and lipopolysaccharides: role for lysine residues in antimicrobial properties.

Authors:  Wendy H J Beck; Christopher P Adams; Ivan M Biglang-Awa; Arti B Patel; Heather Vincent; Eric J Haas-Stapleton; Paul M M Weers
Journal:  Biochim Biophys Acta       Date:  2013-02-26

7.  Serological reactivity and biochemical characterization of methylated and unmethylated forms of a recombinant protein fragment derived from outer membrane protein B of Rickettsia typhi.

Authors:  Chien-Chung Chao; Zhiwen Zhang; Hui Wang; Abdulnaser Alkhalil; Wei-Mei Ching
Journal:  Clin Vaccine Immunol       Date:  2008-02-20

8.  A new HDL mimetic peptide that stimulates cellular cholesterol efflux with high efficiency greatly reduces atherosclerosis in mice.

Authors:  John K Bielicki; Haiyan Zhang; Yuan Cortez; Ying Zheng; Vasanthy Narayanaswami; Arti Patel; Jan Johansson; Salman Azhar
Journal:  J Lipid Res       Date:  2010-01-14       Impact factor: 5.922

9.  Apolipophorin III lysine modification: Effect on structure and lipid binding.

Authors:  Lesley J Vasquez; Gezman E Abdullahi; Chung-Ping Leon Wan; Paul M M Weers
Journal:  Biochim Biophys Acta       Date:  2009-05-18

10.  Apolipoprotein A-I tryptophan substitution leads to resistance to myeloperoxidase-mediated loss of function.

Authors:  Dao-Quan Peng; Gregory Brubaker; Zhiping Wu; Lemin Zheng; Belinda Willard; Michael Kinter; Stanley L Hazen; Jonathan D Smith
Journal:  Arterioscler Thromb Vasc Biol       Date:  2008-08-07       Impact factor: 8.311

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.